Effect of Pulmonary Hypertension Severity on Graft Function and Quality of Life after Transplantation in Patients with End-Stage Renal Disease

Document Type : Original Article


1 Department of Internal Medicine, Faculty of Medicine, Ardabil University of Medical Science, Ardabil, Iran.

2 Department of Community Medicine, Faculty of Medicine, Ardabil University of Medical Science, Ardabil, Iran.

3 Faculty of Medicine, Ardabil University of Medical Science, Ardabil, Iran.


The present study aimed to assess the effect of pulmonary hypertension (PH) severity on the quality of life after transplantation in patients with end-stage renal disease (ESRD).
Materials and Methods:
In this cohort study, 60 ESRD patients who underwent kidney transplantation were followed for at least one year. Basic and laboratory findings were recorded in patients before and after transplantation. Quality of life was assessed by the 12-item health-related quality of life questionnaire (SF-12). The severity of PH was assessed based on pulmonary artery systolic pressure (PASP), and severe cases were excluded from the study. The obtained data were analyzed in SPSS software (version 24) using the chi-square test, independent t-test, and Pearson's correlation.
Based on the results, PH was observed in 83.3% of patients before transplantation. Following transplantation, there was a significant increase in quality of life and glomerular filtration rate (GFR) (P=0.001). Patients with PH had a lower quality of life before transplantation, as compared to those without PH (P= 0.009). Furthermore, the PASP level showed a significant positive relationship with the age of patients (r= 0.465; P<0.001) and the rate of improvement in quality of life after transplantation (r=0.288; P= 0.02).
As evidenced by the results of this study, kidney transplantation improves kidney function and the quality of life of patients. The presence of PH leads to lower quality of life in ESRD patients before transplantation but has no effect on it after transplantation. Moreover, the severity of PH had no effect on the outcomes of a kidney transplant.


  1. Zelmer JL. The economic burden of end-stage renal disease in Canada. Kidney Int 2007; 72:1122-1129.
  2. Prodjosudjadi W. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia. Ethn Dis 2006; 16(2 Suppl 2):S2-14-16.
  3. Mahdavi-Mazdeh M, Heidary RA, Norouzi Sh, Aghighi M, Rajolani H, Ahrabi S. Renal replacement therapy in Iran. Urol J 2007; 4:66-70.
  4. Kovacs G, Dumitrescu D, Barner A, Greiner S, Grünig E, Hager A, et al. Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 2018. pii: S0167-5273(18)34347-X.
  5. Agarwal R. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transplant 2012; 27:3908-14.
  6. Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, Abassi Z, et al. Pulmonary hypertension in patients with end-stage renal disease. Chest 2003; 123: 1577-82.
  7. Li Z, Liang X, Liu S, Ye Z, Chen Y, Wang W, et al. Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS One 2014;9:e 114392.
  8. Pabst S, Hammerstingl C, Hundt F, Gerhardt T, Grohé C, Nickenig G, et al. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study. PLoS One 2012; 7:e35310.
  9. Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, et al. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol 2014; 9: 855-63.
  10. Suresh H, Arun BS, Moger V, Vijayalaxmi PB, Murali Mohan KTK. A prospective study of pulmonary hypertension in patients with chronic kidney disease: a new and pernicious complication. Indian J Nephrol 2018; 28:127–134.
  11. Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ 2005; 173: 1181–1184.
  12. Tang M, Batty JA, Lin C, Fan X, Chan KE, Kalim S. Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: a systematic review and meta-analysis. Am J Kidney Dis 2018; 72:75–83.
  13. Bozbas SS, Kanyilmaz S, Akcay S, et al. Renal transplant improves pulmonary hypertension in patients with end stage renal disease. Multidiscip Respir Med. 2011; 6:155–160.
  14. Wang SC, Garcia R, Torosoff M, Fein SA, Ashar A, Chandolias N, et al. Influence of mildly and moderately elevated pulmonary artery systolic pressure on post-renal transplantation survival and graft function. Echocardiography 2018; 00:1–6.
  15. Issa N1, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. 2008; 86:1384-8.
  16. Kazory A, Ross EA. Pulmonary Arterial Hypertension and the Kidney: Getting to the Heart of the Matter. Am J Nephrol 2018; 47:130-133.
  17. Foderaro AE, Baird GL, Bazargan-Lari A, Morrissey PE, Gohh RY, Poppas A, et al. Echocardiographic Pulmonary Hypertension Predicts Post transplantation Renal Allograft Failure. Transplant Proc 2017;49:1256-1261.
  18. Goyal VK, Solanki SL, Baj B. Pulmonary hypertension and post-operative outcome in renal transplant: A retrospective analysis of 170 patients. Indian J Anaesth 2018; 62:131-135.
  19. Mathai SC, Suber T, Khair RM, Kolb TM, Damico RL, Hassoun PM. Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension. Ann Am Thorac Soc 2016; 13(1): 31-9.
  20. Von der Lippe N, Waldum-Grevbo B, Varberg Reisæter A, Os I. Is HRQUALITY OF LIFE in dialysis associated with patient survival or graft function after kidney transplantation? BMC Nephrol. 2016; 17:94.
  21. Von der Lippe N, Waldum B, Brekke FB, Amro AA, Reisæter AV, Os I. From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life. BMC Nephrol. 2014; 15:191.
  22. Kostro JZ, Hellmann A, Kobiela J, Skóra I, Lichodziejewska-Niemierko M, Dębska-Ślizień A, et al. Quality of Life After Kidney Transplantation: A Prospective Study. Transplant Proc. 2016; 48(1):50-4.
  23. Iqbal MM, Rahman N, Alam M, Deb Nath PK, Waheed S, Islam K, et al. Quality of Life Is Improved in Renal Transplant Recipients Versus That Shown in Patients With Chronic Kidney Disease With or Without Dialysis. Exp Clin Transplant. 2020; 18(Suppl 1):64-67.
  24. Cannavò A, Passamonti SM, Vincenti D, Aurelio MT, Torelli R, Poli F, et al. Quality of Life Before and After Transplantation in Solid Organ Recipients Referred to the North Italy Transplant program (NITp): A Cross-sectional Study. Transplant Proc. 2019; 51(6):1692-1698.
  25. Mouelhi Y, Jouve E, Alessandrini M, Pedinielli N, Moal V, Meurette A, et al. Factors associated with Health-Related Quality of Life in Kidney Transplant Recipients in France. BMC Nephrol. 2018; 19(1):99.
  26. Reis A, Santos M, Vicente M, Furtado I, Cruz C, Melo A, et al. Health-Related Quality of Life in Pulmonary Hypertension and Its Clinical Correlates: A Cross-Sectional Study. Biomed Res Int. 2018; 2018:3924517.
  27. Kıvanç T, Kal Ö, Çiftçi Ö, Akçay Ş. Relation Between Pulmonary Hypertension and Health-Related Quality of Life in Patients Undergoing Hemodialysis. Exp Clin Transplant. 2016; 14 (Suppl 3): 59-63.
  28. Bozbas SS, Akcay S, Altin C, Bozbas H, Karacaglar E, Kanyilmaz S, et al. Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Transplant Proc. 2009; 41:2753–6.
  29. Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, et al. Pulmonary hypertension in patients with chronic renal failure. Respiration 2007; 74:503-510.
  30. Abassi Z, Nakhoul F, Khankin E, Reisner SA, Yigla M. Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective. Curr Opin Nephrol Hypertens 2006; 15:353-360.